# Xellia (Taizhou) Pharmaceuticals – FDA Inspection, Apr 6, 2018

Source: https://www.keypedia.com/records/fda_inspections/xellia-taizhou-pharmaceuticals/efd3b62d-c1cc-45b9-a741-0d826895654f
Source feed: FDA_Inspections

> FDA inspection 1051248 of Xellia (Taizhou) Pharmaceuticals, April 06, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1051248
- Company Name: Xellia (Taizhou) Pharmaceuticals
- Inspection Date: 2018-04-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1330508 - 2026-07-03
- FDA Inspection 923425 - 2015-03-26
- FDA Inspection 801705 - 2012-09-20
- FDA Inspection 570393 - 2009-02-27

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kham-phommachanh/cc7e728e-d2a1-469d-be3a-4f5fdd43b2dc)

Company: https://www.keypedia.com/companies/xellia-taizhou-pharmaceuticals/d0debe75-9c46-480f-a6b6-4695ad2bb771

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c